LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.01
 6.94 771.67 987 1045 0.9444 0.7549
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 9.16 771.67 1102 1138 0.9679 0.8872
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 9.16 771.67 1090 1138 0.9574 0.8507
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 11.56 771.67 1180 1280 0.9214 0.7881
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 11.56 771.67 1222 1280 0.9542 0.8758
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 13.78 771.67 1344 1459 0.9207 0.8282
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 13.78 771.67 1388 1459 0.9509 0.8933
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 16.00 771.67 1499 1585 0.9454 0.8949
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 16.00 771.67 1497 1585 0.9442 0.8924
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 18.22 771.67 1595 1741 0.9159 0.8559
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 18.22 771.67 1655 1741 0.9504 0.9152
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 20.44 771.67 1704 1910 0.8917 0.8323
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 20.44 771.67 1766 1910 0.9242 0.8830
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 22.66 771.67 1858 2141 0.8676 0.8161
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 22.66 771.67 1923 2141 0.8980 0.8591
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 24.89 771.67 2059 2397 0.8587 0.8222
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 24.89 771.67 2132 2397 0.8892 0.8614
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 27.11 771.67 2338 2675 0.8740 0.8553
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 27.11 771.67 2420 2675 0.9046 0.8913
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 29.33 771.67 2603 2939 0.8856 0.8779
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 29.33 771.67 2708 2939 0.9213 0.9168
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 31.55 771.67 2818 3196 0.8815 0.8807
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 31.55 771.67 3068 3196 0.9597 0.9603
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 33.78 771.67 3008 3499 0.8595 0.8659
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 33.78 771.67 3351 3499 0.9575 0.9606
MN20160304_L01
F13